Act Now to Perform Retrospective Analysis of Past Phase II, III Alzheimer’s Clinical Trials

Act Now to Perform Retrospective Analysis of Past Phase II, III Alzheimer’s Clinical Trials

By Vesna Prchkovska | News, Expertise, Alzheimer

A Landmark FDA Approval For Alzheimer’s Shakes Up Industry On June 7th, 2021, accelerated regulatory approval was granted for Alzheimer’s drug, Aduhelm (aducanumab), designed to slow cognitive...